Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 24, 2012; 78 (1 Supplement) April 24,2012

Meningitis after Vaccination in United States, a Report from the CDC/FDA Vaccine Adverse Event Reporting System [1990–2010] (P03.243)

Zubeda Sheikh, Wael Abukwaik, Nizar Souayah
First published February 8, 2016,
Zubeda Sheikh
1 New Jersey Medical school Newark NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wael Abukwaik
2 New Jersey Medical School Newark NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nizar Souayah
3 New Jersey Mdical School Westfield NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Meningitis after Vaccination in United States, a Report from the CDC/FDA Vaccine Adverse Event Reporting System [1990–2010] (P03.243)
Zubeda Sheikh, Wael Abukwaik, Nizar Souayah
Neurology Apr 2012, 78 (1 Supplement) P03.243;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: To determine the rate and characteristics of the occurrence of meningitis after administration of vaccination in the United States.

Background There are several reports of meningitis after vaccination.

Design/Methods: We used data from the Vaccine Adverse Event Reporting System (VAERS), which is a cooperative program for vaccine safety of the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). VAERS is a post-marketing safety surveillance program, collecting information about adverse events (possible side effects) that occur after the administration of United States licensed vaccines.

Results: There were 722 cases (mean age 9.3 years, range 0.1 to 74.7 years) of meningitis reported after vaccination in the United States, from 1990 to 2010. The onset of meningitis was within 6 weeks after vaccination in 415 cases (57.5%), and within 2 weeks in 327(45.2%), when the date of vaccination is known. Hospitalization and disability were reported in, respectively, 549 (76%) and 50 (6.9%) patients. Meningitis was reported in: 314 cases (43%) after hemophilus influenza b vaccination, 115 cases (15.9%) after administration of the hepatitis B vaccine, 114 (15%) after oral polio vaccination, 104 (14.4%) after DTP (Diphtheria, Tetanus Toxoid, and Pertussis) vaccination, 89 (12.3%) following DTAP (Diphtheria, Tetanus Toxoids, and acellular Pertussis) vaccination, 88 cases (12.1%) after PNC (heptavalent Pneumococcal protein conjugate) vaccination, 84 cases (11.6%) after MMR vaccination, and 67 cases (9.2%) after IPV (Inactivated polio virus) vaccination.

Conclusions: The unbalanced distribution of reports of meningitis in the first 6 weeks after vaccination is suggestive of the possibility that some cases may be triggered by vaccination.

Disclosure: Dr. Shekh has nothing to disclose. Dr. Abukwaik has nothing to disclose. Dr. Souayah has received personal compensation for activities with Walgreens as a consultant. Dr. Souayah has received research support from Talecris.

Tuesday, April 24 2012, 14:00 pm-18:30 pm

  • Copyright © 2011 by AAN Enterprises, Inc.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 96 (3)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise